213 related articles for article (PubMed ID: 6211319)
1. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
England PC; Sellwood RA; Knyba RE; Irvine JD
Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
[No Abstract] [Full Text] [Related]
2. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
3. Endocrine aspects of benign breast disease.
Parlati E; Liberale I; Travaglini A; Morelli P; Menini E; Dell'Acqua S
Cancer Detect Prev; 1992; 16(1):25-6. PubMed ID: 1312904
[TBL] [Abstract][Full Text] [Related]
4. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
Sokolova ZP
Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
[No Abstract] [Full Text] [Related]
5. Serum prolactin, androgens, oestradiol and progesterone in adolescent girls with or without a family history of breast cancer.
Boffard K; Clark GM; Irvine JB; Knyba RE; Bulbrook RD; Wang DY; Kwa HG
Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1071-7. PubMed ID: 6461557
[No Abstract] [Full Text] [Related]
6. Benign breast disease I: hormonal investigation.
Sitruk-Ware R; Sterkers N; Mauvais-Jarvis P
Obstet Gynecol; 1979 Apr; 53(4):457-60. PubMed ID: 571588
[TBL] [Abstract][Full Text] [Related]
7. [Endocrine markers in benign breast diseases].
Thalabard JC; Sitruk-Ware R; Kuttenn F; Mauvais-Jarvis P
Zentralbl Gynakol; 1986; 108(6):354-8. PubMed ID: 3716674
[TBL] [Abstract][Full Text] [Related]
8. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
Watt-Boolsen S; Andersen AN; Blichert-Toft M
Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
[TBL] [Abstract][Full Text] [Related]
9. [Benign breast diseases: hormonal studies in 125 cases (author's transl)].
Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Sitruk-Ware R
Nouv Presse Med; 1977 Dec; 6(44):4115-8. PubMed ID: 600762
[TBL] [Abstract][Full Text] [Related]
10. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions.
Miller WR; Humeniuk V; Forrest AP
Breast Cancer Res Treat; 1981; 1(3):267-72. PubMed ID: 6216932
[TBL] [Abstract][Full Text] [Related]
12. Endocrinology of benign breast disease in relation to the severity of radiological dysplasia.
Junkermann H; Klinga K; Weber E; von Fournier D
Horm Res; 1989; 32 Suppl 1():10-4. PubMed ID: 2613196
[TBL] [Abstract][Full Text] [Related]
13. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
[TBL] [Abstract][Full Text] [Related]
14. [Hormonal function of the ovarian corpus luteum during benign mammary diseases].
Mauvais-Jarvis P; Tamborini A; Sterkers N; Ohlgiesser G; Mowszowicz I
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):965-70. PubMed ID: 1219052
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Prolactin in benign and malignant breast disease.
Cole EN; England PC; Sellwood RA; Griffiths K
J Endocrinol; 1976 Jun; 69(3):49P-50P. PubMed ID: 950543
[No Abstract] [Full Text] [Related]
16. Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease.
Olsson H; Landin-Olsson M; Gullberg B
J Natl Cancer Inst; 1983 Jan; 70(1):17-20. PubMed ID: 6571912
[TBL] [Abstract][Full Text] [Related]
17. Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.
Parlati E; Travaglini A; Liberale I; Menini E; Dell'Acqua S
J Endocrinol Invest; 1988 Oct; 11(9):679-83. PubMed ID: 2975693
[TBL] [Abstract][Full Text] [Related]
18. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
[TBL] [Abstract][Full Text] [Related]
19. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
[TBL] [Abstract][Full Text] [Related]
20. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
